questionsmedicales.fr
Eucaryotes
Champignons
Deuteromycota
Chrysosporium
Chrysosporium : Questions médicales fréquentes
Termes MeSH sélectionnés :
High-Throughput Screening Assays
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chrysosporium : Questions médicales les plus fréquentes",
"headline": "Chrysosporium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chrysosporium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chrysosporium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Deuteromycota",
"url": "https://questionsmedicales.fr/mesh/D003904",
"about": {
"@type": "MedicalCondition",
"name": "Deuteromycota",
"code": {
"@type": "MedicalCode",
"code": "D003904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.300.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chrysosporium",
"alternateName": "Chrysosporium",
"code": {
"@type": "MedicalCode",
"code": "D002912",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anwei Chen",
"url": "https://questionsmedicales.fr/author/Anwei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn."
}
},
{
"@type": "Person",
"name": "Liang Hu",
"url": "https://questionsmedicales.fr/author/Liang%20Hu",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn."
}
},
{
"@type": "Person",
"name": "Sheng-Tao Yang",
"url": "https://questionsmedicales.fr/author/Sheng-Tao%20Yang",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn."
}
},
{
"@type": "Person",
"name": "Ni He",
"url": "https://questionsmedicales.fr/author/Ni%20He",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China."
}
},
{
"@type": "Person",
"name": "Motoyuki Shimizu",
"url": "https://questionsmedicales.fr/author/Motoyuki%20Shimizu",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Biomarkers in Cancer Screening: Promises and Challenges in Cancer Early Detection.",
"datePublished": "2024-05-22",
"url": "https://questionsmedicales.fr/article/38782647",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.hoc.2024.04.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evolution of Pathological Techniques for the Screening of Cervical Cancer: A Comprehensive Review.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38903362",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.60769"
}
},
{
"@type": "ScholarlyArticle",
"name": "CRISPR/Cas9 screening: unraveling cancer immunotherapy's 'Rosetta Stone'.",
"datePublished": "2024-05-18",
"url": "https://questionsmedicales.fr/article/38763850",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.molmed.2024.04.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "A personalized osteoarthritic joint-on-a-chip as a screening platform for biological treatments.",
"datePublished": "2024-05-06",
"url": "https://questionsmedicales.fr/article/38757057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mtbio.2024.101072"
}
},
{
"@type": "ScholarlyArticle",
"name": "Educating Nurses in Sleep Screening, Brief Intervention, and Referral for Treatment.",
"datePublished": "2024-05-03",
"url": "https://questionsmedicales.fr/article/38696779",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/00220124-20240426-03"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Champignons",
"item": "https://questionsmedicales.fr/mesh/D005658"
},
{
"@type": "ListItem",
"position": 4,
"name": "Deuteromycota",
"item": "https://questionsmedicales.fr/mesh/D003904"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chrysosporium",
"item": "https://questionsmedicales.fr/mesh/D002912"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chrysosporium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chrysosporium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chrysosporium",
"description": "Comment diagnostiquer une infection par Chrysosporium ?\nQuels tests sont utilisés pour identifier Chrysosporium ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent une infection par Chrysosporium ?\nPeut-on utiliser des tests sérologiques pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=High-Throughput+Screening+Assays&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chrysosporium",
"description": "Quels sont les symptômes courants d'une infection fongique ?\nLes infections cutanées par Chrysosporium sont-elles fréquentes ?\nComment se manifestent les infections pulmonaires ?\nLes infections systémiques sont-elles graves ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=High-Throughput+Screening+Assays&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chrysosporium",
"description": "Comment prévenir les infections par Chrysosporium ?\nLes personnes immunodéprimées doivent-elles prendre des précautions ?\nLe port de gants est-il recommandé lors de manipulations ?\nLes vaccinations aident-elles à prévenir ces infections ?\nL'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=High-Throughput+Screening+Assays&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chrysosporium",
"description": "Quels traitements sont efficaces contre Chrysosporium ?\nLes traitements varient-ils selon la gravité de l'infection ?\nCombien de temps dure le traitement antifongique ?\nDes effets secondaires sont-ils associés aux antifongiques ?\nLes infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=High-Throughput+Screening+Assays&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chrysosporium",
"description": "Quelles complications peuvent survenir avec Chrysosporium ?\nLes infections par Chrysosporium peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles le pronostic ?\nLes infections récurrentes sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=High-Throughput+Screening+Assays&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chrysosporium",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection fongique ?\nLes traitements immunosuppresseurs sont-ils un facteur de risque ?\nLes voyages dans des zones tropicales augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=High-Throughput+Screening+Assays&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Chrysosporium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen microscopique et la culture du champignon."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Chrysosporium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des techniques moléculaires comme la PCR peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être nécessaires pour confirmer l'infection fongique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Chrysosporium ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des lésions cutanées, des infections pulmonaires ou systémiques."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests sérologiques pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques ne sont généralement pas fiables pour Chrysosporium."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection fongique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, éruptions cutanées et fatigue."
}
},
{
"@type": "Question",
"name": "Les infections cutanées par Chrysosporium sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des lésions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections pulmonaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par une toux persistante, des douleurs thoraciques et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections systémiques sont-elles graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être graves et nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Chrysosporium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des environnements humides et à des matériaux contaminés aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les environnements à risque et consulter un médecin régulièrement."
}
},
{
"@type": "Question",
"name": "Le port de gants est-il recommandé lors de manipulations ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de gants lors de la manipulation de terre ou de matériaux potentiellement contaminés est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir ces infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de vaccin spécifique contre les infections par Chrysosporium."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle peut réduire le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre Chrysosporium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques comme l'itraconazole et le voriconazole sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la gravité de l'infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections légères peuvent être traitées par voie orale, tandis que les cas graves nécessitent une perfusion."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement antifongique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement peut varier de plusieurs semaines à plusieurs mois selon la gravité."
}
},
{
"@type": "Question",
"name": "Des effets secondaires sont-ils associés aux antifongiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées et des problèmes hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'infection; les cas graves peuvent nécessiter une hospitalisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Chrysosporium ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections systémiques graves et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en particulier chez les personnes immunodéprimées, elles peuvent être fatales."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements antifongiques intensifs et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de complications peut aggraver le pronostic et prolonger la durée de traitement."
}
},
{
"@type": "Question",
"name": "Les infections récurrentes sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections récurrentes peuvent survenir, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, le diabète et l'exposition à des environnements humides."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il le risque d'infection fongique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs sont-ils un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones tropicales augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones tropicales peuvent exposer à des agents pathogènes fongiques."
}
}
]
}
]
}
Cancer continues to be one the leading causes of death worldwide, primarily due to the late detection of the disease. Cancers detected at early stages may enable more effective intervention of the dis...
The evolutionary journey of cervical cancer screening has been a major medical success story, considering the substantial role it has played in dwindling the disease burden. Through sustained collabor...
Clustered regularly interspaced palindromic repeats (CRISPR)-based technology, a powerful toolset for the unbiased functional genomic screening of biological processes, has facilitated several scienti...
Osteoarthritis (OA) is a highly disabling pathology, characterized by synovial inflammation and cartilage degeneration. Orthobiologics have shown promising results in OA treatment thanks to their abil...
Poor sleep is an unrecognized problem among cancer survivors that affects quality of life. However, screening for sleep disorders is not routine in cancer care. To fill this gap, a self-paced online t...
A three-phase evaluation pilot study included the following steps: (a) develop an online training program with in situ simulation; (b) implement the program with RNs at a comprehensive cancer center; ...
Of the 22 RNs participating, 17 completed online modules and in situ simulation. The RNs were satisfied (...
The RNs gained knowledge applying Sleep-SBIRT, but future larger studies are warranted....
Phenotype based screening is a powerful tool to evaluate cellular drug response. Through high content fluorescence imaging of simple fluorescent labels and complex image analysis phenotypic measuremen...
Screening for lung cancer using low-dose computed tomography is associated with reduced lung cancer-specific mortality, but uptake is low in the US; understanding how patients make decisions to engage...
To investigate environmental, psychosocial, and modifying factors influencing lung cancer screening decision-making and develop a conceptual framework depicting relationships between these factors....
This multimethod qualitative study was conducted from December 2021 to June 2022 using virtual semistructured interviews and 4 focus groups (3-4 participants per group). All participants met US Preven...
Key factors influencing screening decisions (eg, knowledge, beliefs, barriers, and facilitators) were the main outcome. A theory-informed, iterative inductive-deductive approach was applied to analyze...
Among 34 total participants (interviews, 20 [59%]; focus groups, 14 [41%]), mean (SD) age was 59.1 (4.8) years and 20 (59%) identified as female. Half had a household income below $20 000 (17 [50%]). ...
In this qualitative study of patient lung cancer screening decisions, environmental, psychosocial, and modifying factors influenced screening decisions. The findings suggest that systems-level interve...
Detailed molecular understanding of the human organism is essential to develop effective therapies. Saccharomyces cerevisiae has been used extensively for acquiring insights into important aspects of ...
Walnuts play a positive role in human health due to their large amounts of unsaturated fatty acids, whereas lipid oxidation can easily occur during storage. Herein, three natural antioxidants (epicate...
Reducing disparities in colorectal cancer (CRC) screening rates and mortality remains a priority. Mitigation strategies to reduce these disparities have largely been unsuccessful. The primary aim is t...
A cross-sectional analysis of publicly available data across North Carolina using variable reduction techniques with clustering to evaluate association of CRC screening rates and mortality was perform...
Three million sixty-five thousand five hundred thirty-seven residents (32.1%) were aged 50 y or more. More than two-thirds (68.8%) were White, while 20.5% were Black. Approximately 61% aged 50 y or mo...
In North Carolina, using variable reduction with clustering, CRC screening rates were associated with the inter-relationship of the number of providers and rurality, while CRC mortality was associated...